Reductive Dehalogenation in Mammals by Iodotyrosine Deiodinase
Reductive Dehalogenation in Mammals by Iodotyrosine Deiodinase
批准号:
8503704
负责人:
STEVEN E ROKITA
金额:
$30.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-15 至 2014-04-30
关键词:
Active SitesAlanineAmino AcidsAnabolismBacteriaBindingBiologicalBiologyCatalysisChemistryCongenital AbnormalityCrystallizationDataDependenceDietDistantElectronsEnvironmentEnzymesEvolutionFamilyFlavinsFlavoproteinsFundingHealthHomeostasisHomologous GeneHormonesHumanHuman ActivitiesHydrogen BondingHydrolysisHypothyroidismInvestigationIodide PeroxidaseIodidesIodineLifeMammalsMeasuresMediatingMetabolicMetabolismMicrobeMono-SNADH oxidaseNADPOrganismOxidation-ReductionOxidoreductasePathway interactionsPersonal SatisfactionPositioning AttributeProcessPropertyProteinsPyrimidineReactionRecruitment ActivityRecyclingRoleSelenocysteineStructureSubstrate InteractionSubstrate SpecificityTestingThyroid GlandThyroxineTimeTissuesTreesanalogbasecarboxyl radicalcofactordehalogenationdeiodinationdesigndietary requirementfascinatefunctional groupgazehormone biosynthesismutantnoveloxidationprogenitorresearch study
中文摘要
描述(申请人提供):有机卤化物通过自然和人类活动在环境中无处不在。大多数生物通过酶介导的水解、消除或氧化来解毒和降解这些化合物。某些微生物也能够促进还原脱卤化,尽管这主要限于厌氧代谢。哺乳动物为这种普遍的观察提供了一个有趣的例外。必需激素--甲状腺激素(3-[4-[4-hydroxy-3,5-diiodophenoxy]-3,5-diiodophenyl]alanine),在多种组织中被含硒半胱氨酸的酶还原脱碘。非常令人惊讶的是,在甲状腺中招募了一种完全不同的策略来脱碘3-碘-酪氨酸和3,5-二碘酪氨酸。在这种情况下,一种独特的黄素蛋白,碘酪氨酸脱碘酶,负责减少碘化氨基酸,以便回收碘重新用于甲状腺激素的生物合成。现在正在进行研究,以确定这种哺乳动物脱碘酶前所未有的化学和机制。这种酶的新性质将扩展已知的黄素依赖催化体系和生物学中可用于处理卤代化合物的途径。我们对催化的描述将集中在IYD中C-I键的还原和伴随的黄素的氧化。光谱分析和产品分析将用于区分单电子过程和两个电子过程,并首次揭示由IYD处理的全部基片。底物和黄素辅因子的激活将通过独立测量酶突变体和底物类似物的识别和催化性能来描述。同时,黄素化学的底物依赖控制将通过其氧化还原性质的变化来检测。这些研究也将通过对IYD的持续结晶学研究而得到丰富。最后,这种不同寻常的脱碘现象的起源将通过表达和表征来自生物的同源基因来检验,这些生物与“生命树”中的哺乳动物相继相继变得更远。与公共健康相关:碘是我们饮食中的必要成分,用于在甲状腺中产生一种含碘的激素,这是调节我们整个身体代谢率所必需的。我们将研究从激素生物合成过程中形成的副产品中回收碘的过程,这对于了解某些先天性缺陷导致甲状腺功能减退的基础至关重要。
英文摘要
DESCRIPTION (provided by applicant): Organohalides are ubiquitous in the environment through natural and human activities. Most organisms detoxify and degrade these compounds by enzyme-mediated hydrolysis, elimination or oxidation. Certain microbes are also capable of promoting reductive dehalogenation, although this is primarily limited to anaerobic metabolism. Mammals provide a fascinating exception to this general observation. The essential hormone, thyroxine (3-[4-[4-hydroxy-3,5-diiodophenoxy]-3,5-diiodophenyl]alanine), is reductively deiodinated in a variety of tissues by selenocysteine-containing enzymes. Quite surprisingly, an entirely different strategy has been recruited in the thyroid to deiodinate 3-iodo- and 3,5-diiodotyrosine. In this case, a unique flavoprotein, iodotyrosine deiodinase, is responsible for reducing the iodinated amino acids in order to salvage iodide for reuse in thyroxine biosynthesis. Investigations are now proposed to identify the unprecedented chemistry and mechanism of this mammalian deiodinase. The novel properties of this enzyme will extend the known repertoire of flavin-dependent catalysis and pathways available in biology to process halogenated compounds. Our description of catalysis will focus on the reduction of the C-I bond and concomitant oxidation of the reduced flavin in IYD. Spectroscopic and product analyses will be used to differentiate between one and two electron processes and, for the first time, reveal the full range of substrates that are processed by IYD. Activation of both the substrate and flavin cofactor will be described by independently measuring recognition and catalytic properties of enzyme mutants and substrate analogues. Concurrently, substrate-dependent control of the flavin chemistry will be detected by changes in its redox properties. These investigations will be enriched as well by continuing crystallographic studies of IYD. Finally, the origins of this unusual deiodination will be examined by expressing and characterizing homologous genes from organisms that are successively more distant from mammals in the "Tree of Life." PUBLIC HEALTH RELEVANCE: Iodide is a necessary component of our diet and used to produce an iodide-containing hormone in the thyroid that is required for regulating the metabolic rate of our entire body. The process by which we recycle iodide from byproducts formed during hormone biosynthesis will be investigated and is crucial to understand the basis for certain congenital defects leading to hypothyroidism.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
A mammalian reductive deiodinase has broad power to dehalogenate chlorinated and brominated substrates.
哺乳动物还原性去二世酶具有脱盐酸盐氯化和溴化底物具有广泛的能力。
DOI:
10.1021/ja906642n
发表时间:
2009-10-14
期刊:
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
影响因子:
15
作者:
[McTamney, Patrick M., Rokita, Steven E.]
通讯作者:
Rokita, Steven E.
DOI:
10.1016/j.abb.2017.07.019
发表时间:
2017-10-15
期刊:
Archives of biochemistry and biophysics
影响因子:
3.9
作者:
[Sun Z, Su Q, Rokita SE]
通讯作者:
Rokita SE
DOI:
10.1021/jacs.5b07540
发表时间:
2015-12-16
期刊:
Journal of the American Chemical Society
影响因子:
15
作者:
[Mukherjee A, Rokita SE]
通讯作者:
Rokita SE
DOI:
10.1021/acs.biochem.5b00410
发表时间:
2015-07-28
期刊:
Biochemistry
影响因子:
2.9
作者:
[Bobyk KD, Ballou DP, Rokita SE]
通讯作者:
Rokita SE
Efficient use and recycling of the micronutrient iodide in mammals.
哺乳动物中微量营养素碘化物的有效利用和回收。
DOI:
10.1016/j.biochi.2010.02.013
发表时间:
2010
期刊:
Biochimie
影响因子:
3.9
作者:
[Rokita,StevenE, Adler,JenniferM, McTamney,PatrickM, WatsonJr,JamesA]
通讯作者:
WatsonJr,JamesA
The Chemistry-Biology Interface Program at Johns Hopkins University
-
批准号:10627441
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2023
-
负责人:STEVEN E ROKITA
-
依托单位:
Switching Between One and Two Electron Mechanisms in the Nitroreductase Superfamily
-
批准号:10090611
-
项目类别:
-
资助金额:$31.64万
-
财政年份:2019
-
负责人:STEVEN E ROKITA
-
依托单位:
The Role of a Dehalogenase in Drosophila Spermatogenesis
-
批准号:8952629
-
项目类别:
-
资助金额:$23.42万
-
财政年份:2015
-
负责人:STEVEN E ROKITA
-
依托单位:
Reductive Dehalogenation in Mammals by Iodotyrosine Deiodinase
-
批准号:8499664
-
项目类别:
-
资助金额:$1.83万
-
财政年份:2009
-
负责人:STEVEN E ROKITA
-
依托单位:
Reductive Dehalogenation in Mammals by Iodotyrosine Deiodinase
-
批准号:8064636
-
项目类别:
-
资助金额:$31.21万
-
财政年份:2009
-
负责人:STEVEN E ROKITA
-
依托单位:
Biosynthesis of Pyrrolo[1,4]benzodiazepines, potent antitumor antibiotics
-
批准号:7930272
-
项目类别:
-
资助金额:$17.39万
-
财政年份:2009
-
负责人:STEVEN E ROKITA
-
依托单位:
Reductive Dehalogenation in Mammals by Iodotyrosine Deiodinase
-
批准号:7698635
-
项目类别:
-
资助金额:$34.25万
-
财政年份:2009
-
负责人:STEVEN E ROKITA
-
依托单位:
Reductive Dehalogenation in Mammals by Iodotyrosine Deiodinase
-
批准号:7871329
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2009
-
负责人:STEVEN E ROKITA
-
依托单位:
The Chemistry-Biology Interface Program at Johns Hopkins University
-
批准号:10202632
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2008
-
负责人:STEVEN E ROKITA
-
依托单位:
The Chemistry-Biology Interface Program at Johns Hopkins University
-
批准号:8690096
-
项目类别:
-
资助金额:$22.57万
-
财政年份:2008
-
负责人:STEVEN E ROKITA
-
依托单位:
The Chemistry-Biology Interface Program at Johns Hopkins University
-
批准号:10412016
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2008
-
负责人:STEVEN E ROKITA
-
依托单位:
Biosynthesis of Pyrrolo[1,4]benzodiazepines, potent antitumor antibiotics
-
批准号:8037037
-
项目类别:
-
资助金额:$23.46万
-
财政年份:2008
-
负责人:STEVEN E ROKITA
-
依托单位:
The Chemistry-Biology Interface Program at Johns Hopkins University
-
批准号:8475061
-
项目类别:
-
资助金额:$22.33万
-
财政年份:2008
-
负责人:STEVEN E ROKITA
-
依托单位:
Biosynthesis of Pyrrolo[1,4]benzodiazepines, potent antitumor antibiotics
-
批准号:7777804
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2008
-
负责人:STEVEN E ROKITA
-
依托单位:
Biosynthesis of Pyrrolo[1,4]benzodiazepines, potent antitumor antibiotics
-
批准号:8486582
-
项目类别:
-
资助金额:$17.49万
-
财政年份:2008
-
负责人:STEVEN E ROKITA
-
依托单位:
Biosynthesis of Pyrrolo[1,4]benzodiazepines, potent antitumor antibiotics
-
批准号:8228017
-
项目类别:
-
资助金额:$6.25万
-
财政年份:2008
-
负责人:STEVEN E ROKITA
-
依托单位:
TARGET PROMOTED ALKYLATION OF NUCLEIC ACIDS
-
批准号:6164315
-
项目类别:
-
资助金额:$23.96万
-
财政年份:1999
-
负责人:STEVEN E ROKITA
-
依托单位:
Target Promoted Alkylation of Nucleic Acids
-
批准号:7393199
-
项目类别:
-
资助金额:$24.44万
-
财政年份:1999
-
负责人:STEVEN E ROKITA
-
依托单位:
TARGET PROMOTED ALKYLATION OF NUCLEIC ACIDS
-
批准号:6362713
-
项目类别:
-
资助金额:$24.68万
-
财政年份:1999
-
负责人:STEVEN E ROKITA
-
依托单位:
TARGET PROMOTED ALKYLATION OF NUCLEIC ACIDS
-
批准号:2850477
-
项目类别:
-
资助金额:$22.05万
-
财政年份:1999
-
负责人:STEVEN E ROKITA
-
依托单位:
海外基金